Digestive Cancer Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China.
Institute of Translational Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China.
Oncogene. 2018 Feb 22;37(8):1041-1048. doi: 10.1038/onc.2017.398. Epub 2017 Oct 30.
Dietary restriction (DR) delays the incidence and decreases the growth of various types of tumors; however, the mechanisms responsible for DR-mediated antitumor effects have not been unequivocally identified. Here, we report that DR suppresses xenograft tumor growth by upregulating a novel signaling pathway. DR led to upregulated aldolase A (ALDOA) expression in xenograft tumors. ALDOA physically interacted with the catalytic subunit of DNA-dependent protein kinase (DNA-PK) and promoted DNA-PK activation. Activated DNA-PK phosphorylated p53 and increased its activity. Although ALDOA can function as an oncogene in cultured cells, it can also activate the tumor suppressor p53. Thus, ALDOA overexpression in the presence of p53 suppressed xenograft tumor growth; however, when p53 was suppressed, ALDOA overexpression promoted xenograft tumor growth. Moreover, we demonstrated that p53 suppression inhibited the antitumor effects of DR. Our results indicate that upregulation of the ALDOA/DNA-PK/p53 pathway is a mechanism accounting for the antitumor effects of DR.
饮食限制(DR)可延缓多种类型肿瘤的发生并抑制其生长;然而,DR 介导的抗肿瘤作用的机制尚未明确。本研究报道 DR 通过上调一种新的信号通路抑制异种移植瘤生长。DR 导致异种移植瘤中醛缩酶 A(ALDOA)的表达上调。ALDOA 与 DNA 依赖性蛋白激酶(DNA-PK)的催化亚基相互作用,并促进 DNA-PK 激活。激活的 DNA-PK 磷酸化 p53 并增加其活性。虽然在培养细胞中 ALDOA 可以作为癌基因发挥作用,但它也可以激活肿瘤抑制因子 p53。因此,在存在 p53 的情况下,ALDOA 的过表达抑制异种移植瘤的生长;然而,当抑制 p53 时,ALDOA 的过表达促进异种移植瘤的生长。此外,我们证明 p53 抑制抑制了 DR 的抗肿瘤作用。我们的结果表明,ALDOA/DNA-PK/p53 通路的上调是 DR 抗肿瘤作用的一种机制。